ACADIA Pharmaceuticals Inc.   (NASDAQ:ACAD)

22.11    $-0.94   -4.08%
Market open   Tuesday, Jan 18 2022 10:46 AM

ACADIA Pharmaceuticals Inc. Chart

ACAD Stock Price Today

ACADIA Pharmaceuticals Inc. (ACAD) stock plummeted over -4.08% intraday to trade at $22.11 a share on NASDAQ. The stock opened with a loss of -1.17% at $22.78 and touched an intraday high of $23.07, rising 0.09% against the last close of $23.05. The stock went to a low of $21.66 during the session.

Stock Snapshot

23.05
Prev. Close
22.78
Open
3.56B
Market Cap
160.66M
Number of Shares
21.66
day Low
23.07
Day High
22.11
-
P/E ratio
4.13%
Free Float in %
-1.20
EPS (TTM)
3.53
Book Value per Share
3.50
Cash Flow per Share
183784
Volume

ACADIA Pharmaceuticals Inc. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2022-01-14$21.86$23.05$23.07$21.661,342,100
2022-01-13$22.20$22.14$22.77$21.631,476,300
2022-01-12$22.68$22.14$22.80$21.851,759,300
2022-01-11$22.65$22.75$23.30$22.32602,100
2022-01-10$22.63$22.71$22.78$21.671,493,100
2022-01-07$23.05$22.59$23.64$22.541,316,000
2022-01-06$23.38$23.39$24.08$22.641,007,700
2022-01-05$24.36$23.11$24.99$23.101,653,200
2022-01-04$24.39$23.62$24.59$23.381,005,600
2022-01-03$23.33$24.39$24.55$23.12916,400
2021-12-31$23.66$23.34$23.73$22.94825,400

Contact Details

12830 El Camino Real
Suite 400
San Diego, CA 92130
United States
https://www.acadia-pharm.com
858 558 2871

Company Information

Employees601
Beta0.62
Sales or Revenue474.40M
5Y Sales Change491.50%
Fiscal Year Ends2020-12-30
SectorHealthcare
IndustryBiotechnology

About Company

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; Trofinetide, a novel synthetic analog for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor for treating cognition and schizophrenia. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.

Frequently Asked Questions

What is the current ACADIA Pharmaceuticals Inc. (ACAD) stock price?

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stock price is $22.11 as of the last check on Tuesday, Jan 18 2022. During the trading session, ACAD stock reached the peak price of $23.07 while $21.66 was the lowest point it dropped to.

ACAD's industry and sector of operation?

The NASDAQ listed ACAD is part of Biotechnology industry that operates in the broader Healthcare sector. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders.

Who are the executives of ACAD?

Mr. Stephen R. Davis J.D.
CEO & Director

Dr. Srdjan R. Stankovic
Pres

Mr. Mark Schneyer
Exec. VP & CFO

Mr. Austin D. Kim
Exec. VP, Gen. Counsel & Sec.


What is the ACAD stock price today?

ACAD stock is trading at $22.11 today, which is $-0.94 or -4.08% lower than its previous close of $23.05. ACAD's current trading price is -59.60% lower than its 52-week high of $54.73 where as its distance from 52-week low of $15.68 is 41.01%.

How many employees does ACAD have?

Number of ACAD employees currently stands at 601. ACAD operates from 12830 El Camino Real Suite 400 San Diego, CA 92130 United States.

Link for ACAD official website?


How do I contact ACAD?

ACAD could be contacted at 12830 El Camino Real Suite 400 San Diego, CA 92130 United States, or at phone # 858 558 2871 and can also be accessed through its website: https://www.acadia-pharm.com

How many shares of ACAD are traded daily?

ACAD stock volume so far today is 183784 shares while in the previous session number of ACAD shares traded was 1.34M. The average number of ACAD shares traded daily for last 3 months was 1.64M.

How much did ACAD change today?

The percentage change in ACAD stock occurred in the recent session was -4.08% while the dollar amount for the price change in ACAD stock was $-0.94.

What price range ACAD stock been trading in?

In the recent session, the day high for ACAD stock was $23.07 while the low for ACAD stock touched on the day was $21.66.

What is the market cap of ACAD currently?

The market value of ACAD currently stands at $3.56B with its latest stock price at $22.11 and 160.66M of its shares outstanding.